CDC Financial »

Inhibrx Biosciences shares owned by CDC Financial

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by CDC Financial from 13F filings

Historical chart of CDC Financial investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by CDC Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by CDC Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 187k 67.23

More positions owned by CDC Financial

Amplify Energy Corp (AMPY)
Century Aluminum Company (CENX)
Inhibrx Biosciences (INBX)
Atlas Energy Solutions Com New (AESI)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Vox Rty Corp Cda F (VOXR)
Apple Put Option (AAPL)
Health Catalyst (HCAT)
Immersion Corporation (IMMR)
Algoma Stl Group (ASTL)
Ring Energy (REI)
Afc Gamma Ord (AFCG)
Servicenow (NOW)
salesforce (CRM)
Inspired Entmt (INSE)

View all positions for CDC Financial

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Vanguard Capital Management
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
State Street Corporation
Millennium Management

View all funds holding Inhibrx Biosciences